1999
DOI: 10.1016/s0002-9149(98)01011-x
|View full text |Cite
|
Sign up to set email alerts
|

Has the survival of the heart failure population changed? lessons from trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
28
0
2

Year Published

2001
2001
2011
2011

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(32 citation statements)
references
References 47 publications
2
28
0
2
Order By: Relevance
“…In the study conducted by Cowie et al [27], with rather bstrictQ diagnostic criteria for HF, the 1-year probability of survival was 0.62. The shape of the survival curve of patients with definite HF is similar to that usually reported in the literature in patients with new diagnosis of HF [10,27,28]. Even survival curves in patients with signs and symptoms of HF but without a stated or confirmed diagnosis show a rapid decline in survival (even less steep than in definite HF) in the first 3 months after the beginning of clinical manifestations.…”
Section: Discussionsupporting
confidence: 82%
“…In the study conducted by Cowie et al [27], with rather bstrictQ diagnostic criteria for HF, the 1-year probability of survival was 0.62. The shape of the survival curve of patients with definite HF is similar to that usually reported in the literature in patients with new diagnosis of HF [10,27,28]. Even survival curves in patients with signs and symptoms of HF but without a stated or confirmed diagnosis show a rapid decline in survival (even less steep than in definite HF) in the first 3 months after the beginning of clinical manifestations.…”
Section: Discussionsupporting
confidence: 82%
“…In particular, evaluation of venous pressure specific for HF, and a third heart sound, are rarely used in their clinical practice. The prevalence of HF defined from the medical records of health centers greatly exceeds that presented in studies using strict criteria (3). Therefore, the false positive HF cases should critically medically evaluated in primary health care, as also previously indicated.…”
Section: Discussionmentioning
confidence: 99%
“…Patients enrolled in this study met the following inclusion criteria: (1) diagnosis of chronic HF from either preserved (left ventricular ejection fraction [LVEF] ≥ 40%) or nonpreserved systolic function (LVEF < 40%); 25 (2) underwent evaluation of HF by a cardiologist and optimization of medical therapy, defined as receiving stable doses of HF medications for 1 month with no plans to add HF medications or titrate further; and (3) able to read and speak English. Patients were excluded if they had (1) obvious cognitive impairment, including not being able to give informed consent or participate in an interview; (2) a coexisting terminal illness, such as cancer or chronic renal failure requiring dialysis; (3) a myocardial infarction within the past 3 months; or (4) a history of cerebral vascular accident within the past 3 months or with major sequelae.…”
Section: Sample and Settingmentioning
confidence: 99%